Live Breaking News & Updates on Gaetan Servais

Stay updated with breaking news from Gaetan servais. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amyl Therapeutics closes €18.3 million Series A financing to develop novel therapies for Amyloidosis


Share this article
Share this article
LIEGE, Belgium, June 3, 2021 /PRNewswire/  Amyl Therapeutics ( Amyl ), a preclinical stage biotechnology company developing its amyloid fibrils specific
 technology platform named ClariTY for the treatment of all forms of Amyloidosis, today announced that it has successfully closed a €18.3 million Series A financing. The funding round comprises €8.6 million in equity led by Noshaq - a regional Belgian private-public fund - with support from Merieux Participations, Sambrinvest and other private investors; and €9.7 million in non-dilutive funding from the DG06 – a key policy-design and implementing body for research and innovation policy in the Walloon region of Belgium. ....

Walloon Region , Waals Gewest , United States , Karine Goraj , Helena Pozios , Kenneth Buckfire , Gaetan Servais , Sylvie Berrebi , Florent Gros , Pierre Vandepapeli , Citigate Dewe Rogerson , Amyl Co , French Financial Markets Authority , Florent Gros Amyl Co , Life Science Foundation , Miller Buckfire Co , Amyl Therapeutics , Merieux Participations , Chief Executive Officer , Chief Medical Officer , Chief Scientific Officer , Managing Partner , Merieux Equity Partners , Miller Buckfire , Amel Tounsi , Investment Manager ,